Literature DB >> 8112477

Azathioprine in combination with steroids in the treatment of autoimmune inner-ear disease.

A Saraçaydin1, S Katircioglu, S Katircioglu, M C Karatay.   

Abstract

A total of twelve patients with a relatively uncommon form of progressive sensorineural deafness (autoimmune inner-ear disease) were treated orally with 1 mg/kg azathioprine, once daily, and with 30 mg prednisolone, every other day, for 4 weeks. Statistically significant increases in the ability to hear pure tones or in discrimination on audiometry took place in 10/12 patients. This condition was initially described as 'sensorineural hearing loss', but it is now clear that the term 'autoimmune inner-ear disease' is more appropriate since the vestibular compartment as well as the cochlear compartment is involved. This relatively uncommon disease is one of the few forms of sensorineural deafness that can be successfully treated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8112477     DOI: 10.1177/030006059302100404

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  6 in total

Review 1.  Immunosuppressive therapy for autoimmune inner ear disease.

Authors:  Maria C Buniel; Katie Geelan-Hansen; Peter C Weber; Vincent K Tuohy
Journal:  Immunotherapy       Date:  2009-05       Impact factor: 4.196

Review 2.  Demystifying autoimmune inner ear disease.

Authors:  Soumyajit Das; Satvinder Singh Bakshi; Ramesh Seepana
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-11       Impact factor: 2.503

3.  Mobile tablet audiometry in fluctuating autoimmune ear disease.

Authors:  Scott Kohlert; Matthew Bromwich
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-03-07

Review 4.  Emerging options in immune-mediated hearing loss.

Authors:  Hitomi Sakano; Jeffrey P Harris
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-12-03

5.  Combination Immunosuppressive Therapy in Primary Autoimmune Inner Ear Disease in Pregnancy.

Authors:  Saikrishna Ananthapadmanabhan; Joe Jabbour; David Brown; Vanaja Sivapathasingam
Journal:  Case Rep Otolaryngol       Date:  2022-03-18

6.  Bone marrow inhibition induced by azathioprine in a patient without mutation in the thiopurine S-methyltransferase pathogenic site: A case report.

Authors:  Xiao-Shuang Zhou; Yuan-Yue Lu; Yan-Fang Gao; Wen Shao; Jia Yao
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.